BioCorRx (BICX) Operating Expenses (2010 - 2026)

BioCorRx (BICX) has 17 years of Operating Expenses data on file, last reported at $1.2 million in Q1 2026.

• Quarterly Operating Expenses rose 9.11% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 51.36% YoY) and the FY2025 annual result came in at $5.6 million, up 9.72% from the prior year.
• Operating Expenses rose to $1.2 million in Q1 2026 per BICX's latest filing, from $383067.0 in the prior quarter.
• The five-year high for Operating Expenses was $1.7 million in Q3 2024, with the low at -$601569.0 in Q3 2025.
• Average Operating Expenses over 5 years is $1.0 million, with a median of $1.1 million recorded in 2022.
• Year-over-year, Operating Expenses soared 70.75% in 2024 and tumbled 136.25% in 2025.
• BioCorRx's Operating Expenses stood at $1.3 million in 2022, then plunged by 33.66% to $841650.0 in 2023, then jumped by 33.64% to $1.1 million in 2024, then tumbled by 65.94% to $383067.0 in 2025, then surged by 205.57% to $1.2 million in 2026.
• Business Quant data shows BICX's Operating Expenses at $1.2 million in Q1 2026, $383067.0 in Q4 2025, and -$601569.0 in Q3 2025.